Detalles de la búsqueda
1.
Regulation of ingestive behaviors in the rat by GSK1521498, a novel micro-opioid receptor-selective inverse agonist.
J Pharmacol Exp Ther
; 339(1): 24-34, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21712426
2.
Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy.
Bioorg Med Chem Lett
; 19(4): 1177-82, 2009 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19138846
3.
Amino acid anthranilamide derivatives as a new class of glycogen phosphorylase inhibitors.
Bioorg Med Chem Lett
; 18(14): 4068-71, 2008 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18554908
4.
Weight and Glucose Reduction Observed with a Combination of Nutritional Agents in Rodent Models Does Not Translate to Humans in a Randomized Clinical Trial with Healthy Volunteers and Subjects with Type 2 Diabetes.
PLoS One
; 11(4): e0153151, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27093610
5.
N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as potent and selective inhibitors of glycogen synthase kinase 3 with good cellular efficacy.
J Med Chem
; 47(19): 4716-30, 2004 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-15341487
6.
Synthesis and evaluation of novel heterocyclic inhibitors of GSK-3.
Bioorg Med Chem Lett
; 16(8): 2091-4, 2006 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16460937
7.
Novel GSK-3 inhibitors with improved cellular activity.
Bioorg Med Chem Lett
; 14(9): 2127-30, 2004 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-15080993
8.
Novel pyrazolopyrimidine derivatives as GSK-3 inhibitors.
Bioorg Med Chem Lett
; 14(9): 2121-5, 2004 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-15080992
Resultados
1 -
8
de 8
1
Próxima >
>>